Library
On this page you can find relevant researchs on drug-related health topics, including HIV, hepatitis C, drug and overdose prevention, harm reduction and drug treatment. You can also find our Clinical Guidelines.
Best Practice Recommendations for Canadian Harm Reduction Programs that Provide Service to People Who Use Drugs and Are at Risk for HIV, HCV and Other Harms: Part 1
Recommendations from Canadian Harm Reduction Network suggesting "new and improved best practice recommendations about needle and syringe distribution, other injection equipment distribution, handling and disposal of used drug-use equipment, and safer drug-use education."
Recommendations from Canadian Harm Reduction Network suggesting "new and improved best practice recommendations about needle and syringe distribution, other injection equipment distribution, handling and disposal of used drug-use equipment, and safer drug-use education."
Global policy report on the prevention and control of viral hepatitis
WHO sets out the results of a survey which they conducted in mid-2012 with the World Hepatitis Alliance. "The survey aimed to gather country-specifi c baseline data on hepatitis policies in WHO Member States in all six regions. Survey data also offered insight into conditions in specific countries that may have hindered past efforts to achieve hepatitis policy objectives."
WHO sets out the results of a survey which they conducted in mid-2012 with the World Hepatitis Alliance. "The survey aimed to gather country-specifi c baseline data on hepatitis policies in WHO Member States in all six regions. Survey data also offered insight into conditions in specific countries that may have hindered past efforts to achieve hepatitis policy objectives."
Coffee Shops and Compromise: Separated Illicit Drug Markets in the Netherlands
Open Society Foundation’s Global Drug Policy Program reports on the history of the Dutch approach to drug policy and describes the ongoing success of the country’s drug policy. "Including the impact of the Dutch “separation of markets,” which potentially limits people’s exposure and access to harder drugs."
Open Society Foundation’s Global Drug Policy Program reports on the history of the Dutch approach to drug policy and describes the ongoing success of the country’s drug policy. "Including the impact of the Dutch “separation of markets,” which potentially limits people’s exposure and access to harder drugs."
Why We Need Drug Policy Reform
Article by Open Society Foundation stating "that the current drug policies are failing and causing enormous harm to individuals and communities. Around the world, poorly designed drug laws that seek to punish production, possession, use, and even dependence have fueled violence, instability, and health crises. It’s time for a new approach."
Article by Open Society Foundation stating "that the current drug policies are failing and causing enormous harm to individuals and communities. Around the world, poorly designed drug laws that seek to punish production, possession, use, and even dependence have fueled violence, instability, and health crises. It’s time for a new approach."
Breaking worse: An Interview with Jean-Paul Grund on the drug 'Krokodil' (film)
Hungarian Civil Liberties Union (HCLU) interview with Grund, J. -P. C., et al. about their new study "Breaking worse: The emergence of krokodil and excessive injuries among people who inject drugs in Eurasia."
Hungarian Civil Liberties Union (HCLU) interview with Grund, J. -P. C., et al. about their new study "Breaking worse: The emergence of krokodil and excessive injuries among people who inject drugs in Eurasia."
Language, identity and HIV: why do we keep talking about the responsible and responsive use of language? Language matters
Letter to the editor of the Journal of International AIDS Society. Which aims to "seek to shift the language used in relation to ourselves, our medical condition, our bodies, our identities and the events we face, towards something more life-enhancing, self-affirming and positive in outlook"
Letter to the editor of the Journal of International AIDS Society. Which aims to "seek to shift the language used in relation to ourselves, our medical condition, our bodies, our identities and the events we face, towards something more life-enhancing, self-affirming and positive in outlook"
The impact of compulsory drug detention exposure on the avoidance of healthcare among injection drug users in Thailand
Thomas Kerr et al. undertook this study in the Mitsampan Community Research Project based in Bangkok. They concluded "that exposure to compulsory drug detention was associated with avoiding healthcare among Thai IDU, suggesting that this system of detention may be contributing to the burden of preventable morbidity among IDU in this setting."
Thomas Kerr et al. undertook this study in the Mitsampan Community Research Project based in Bangkok. They concluded "that exposure to compulsory drug detention was associated with avoiding healthcare among Thai IDU, suggesting that this system of detention may be contributing to the burden of preventable morbidity among IDU in this setting."
Effect of buprenorphine dose on treatment outcome
"How much buprenorphine does it take to keep patients in treatment and suppress illicit use of heroin or other opiate-type drugs? This review concludes that on average higher is better than lower, but that individualising dose and a preparedness to go high if needed are the keys to effective treatment."
"How much buprenorphine does it take to keep patients in treatment and suppress illicit use of heroin or other opiate-type drugs? This review concludes that on average higher is better than lower, but that individualising dose and a preparedness to go high if needed are the keys to effective treatment."
The new danger of synthetic drugs
Editorial published in the Lancet which investigates the wave of novel drugs designed by chemists globally and how policy makers are struggling with this new market. Dr Prosser says “It’s tough as a clinician because even if you do believe the patient is being honest with you, they don’t always know exactly what they’ve taken”, she says. “People will come in and say they used a drug, but they really have no idea.”
Editorial published in the Lancet which investigates the wave of novel drugs designed by chemists globally and how policy makers are struggling with this new market. Dr Prosser says “It’s tough as a clinician because even if you do believe the patient is being honest with you, they don’t always know exactly what they’ve taken”, she says. “People will come in and say they used a drug, but they really have no idea.”
The Challenge of Change:Improving services for women involved in prostitution and substance use
Briefing from DrugScope and Against Violence and Abuse (AVA) makes strategic and policy recommendations to "improve interventions and outcomes for these women, as well as good practice recommendations for services. A key recommendation is to consideration of the specialist needs of this group when planning national strategies and local services, to prevent these women falling through the net, and to encourage them into services"
Briefing from DrugScope and Against Violence and Abuse (AVA) makes strategic and policy recommendations to "improve interventions and outcomes for these women, as well as good practice recommendations for services. A key recommendation is to consideration of the specialist needs of this group when planning national strategies and local services, to prevent these women falling through the net, and to encourage them into services"
